Advisory Research’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-62,602
Closed -$625K 361
2022
Q4
$625K Sell
62,602
-24,476
-28% -$272K 0.06% 221
2022
Q3
$1.04M Buy
+87,078
New +$871K 0.1% 160
2021
Q2
Sell
-92,144
Closed -$1.87M 358
2021
Q1
$1.87M Buy
92,144
+66,107
+254% +$1.31M 0.13% 131
2020
Q4
$466K Buy
+26,037
New +$382K 0.03% 263
2019
Q1
Sell
-24,844
Closed -$508K 346
2018
Q4
$508K Sell
24,844
-13,818
-36% -$432K 0.01% 292
2018
Q3
$1.43M Buy
38,662
+11,497
+42% +$502K 0.02% 232
2018
Q2
$1.36M Buy
+27,165
New +$1.2M 0.02% 244

Other funds holding AXGN

Advisory Research's AXGN Position: Q1 2023 in Review

Advisory Research sold out of Axogen (AXGN) in Q1 2023, closing a stake of 62,602 shares — an estimated $625K sold.

Advisory Research first reported a position in AXGN in Q2 2018 and held it in 7 quarters. The position peaked at $1.87M in Q1 2021. 130 funds tracked by Wall St. Rank hold AXGN as of Q1 2023.

  • Advisory Research reported no remaining Axogen position as of Q1 2023 after selling out during the quarter.
  • Advisory Research sold 62,602 Axogen shares in Q1 2023, an estimated $625K.
  • Advisory Research first reported a position in Axogen in Q2 2018 and held it in 7 quarters.
  • Advisory Research's Axogen position peaked at $1.87M in Q1 2021.
  • 130 funds tracked by Wall St. Rank held Axogen as of Q1 2023.

Based on Advisory Research's 13F filing for Q1 2023, filed 12 May 2023.